147 results on '"Goldman, M."'
Search Results
2. OA2‐AM23‐ST‐13 | Implementation of Sexual Risk‐Based Criteria: Impact on Safety and Adequacy of Supply
3. OA3‐AM23‐MN‐06 | Implementation of Ferritin Testing to Identify Iron Deficiency Amongst Select Whole Blood Donors
4. Correlation of Blood Donor RhD Negative Typing Results Using Two Automated Platforms, Serology and Genotyping: SP292
5. Iron Stores in Whole Blood Donors: SP98
6. Iron Stores in Female Donors Failing Initial Fingerstick Hemoglobin Determination: SP93
7. Evaluation of Screening Questions for Chagas Disease Risk: SP417
8. Mixed Field Reactions in ABO and Rh Typing Due to Chimerism Resulting from Twin Hematopoiesis: SP265
9. Evaluation of the DiaMed ID-PaGIA Microtyping System for Detecting Severe Immunoglobulin A Deficiency and Anti-Human IgA Antibodies: SP226
10. Monitoring the Safety of Donors Participating in a Plasmapheresis Program (2004-2010): SP98
11. Making Maps Reduces Recalls: AP16
12. Impact of High Blood Pressure Defferal on Donor Decision to Seek Medical Attention: AP32
13. Evaluation of the Safety Benefit of Confidential Unit Exclusion: SP455
14. Screening of Canadian Blood Services Donors for Severe IgA Deficiency: SP362
15. Evidence of Patient Specific HLA Antibodies in Canadian TRALI Cases Classified by the 2004 Canadian Consensus Conference Definition: S107-040D
16. TRALI Prevention at Canadian Blood Services: The Evolving Process and Its Impact on TRALI Cases in Canada: S112-040D
17. Bacterial Screening of Outdated Buffy Coat Platelet Pools Using the Bact/ALERT System and Verax Platelet PGD Test: S106-040C
18. Clinical and Laboratory Practices in Investigation of Suspected Transfusion-Transmitted Bacterial Infection: A Survey of Canadian Hospitals: SP469
19. Canadian Blood Services Winnipeg Experience with The Hong Kong Method of Bacterial Detection in WB Platelets After the Implementation of the Sample Diversion Pouch: SP467
20. International Comparison of Red Cell Issues per Capita: *SP433
21. Anti-HPA-1a Antibody Screening and Significance in Canadian Blood Servicesʼ Platelet Registry Donors: SP281
22. The Impact of a Decrease in the Donor Deferral Period for Transmissible Disease Risk Factors from 12 Months To 6 Months: SP200
23. Transfusion-Related Acute Lung Injury: Is Male Plasma the Answer?: *SP173
24. Why Do Hepatitis C Rates Continue to Decrease in First-Time Donors?: SP167
25. Severe Adverse Events In Apheresis Donors: SP3
26. The Effect Of Removing The Upper Age Limit On Blood Donation In Canada: AP45
27. The Blood Donor Screening Questionnaire: Is It Effective?: SP202
28. Efficacy Of Parallel Methods Used To Detect Bacteria In Platelets: SP78
29. Bacterial Detection In Whole Blood Patelets Using The Bac-T Alert In A Centralized Transfusion Service: SP68
30. Mastering the Malaria Muddle: The Value of Simplified Donor Criteria
31. Screening of Blood Donors for IgA Deficiency
32. HPA-5b (Bra) Neonatal Alloimmune Thrombocytopenia in Quebec: Clinical Analysis of 31 Cases Between 1998–2002
33. Neonatal Alloimmune Thrombocytopenia: Incidence of Reported Cases in Quebec from 1998 to 2002 Closing the Gap between Detected and Expected Cases
34. The Declining Value of the Confidential Unit Exclusion Procedure
35. A Pilot Project to Systematically Screen Apheresis Platelets for Bacterial Contamination
36. Validation and Implementation of Diversion
37. Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections
38. Targeted hepatitis C lookback: Quebec, Canada.
39. Evaluation of donor skin disinfection methods.
40. Autologous donation error rates in Canada
41. Validation and implementation of a new hemoglobinometer for donor screening at Canadian Blood Services.
42. Effect of blood transfusion on survival in a mouse bacterial peritonitis model
43. Evaluation of pooled cultures for bacterial detection in whole blood-derived platelets.
44. A fatal case of transfusion-transmitted Staphylococcus epidermidis sepsis.
45. Face-to-face interviewing in predonation screening: lack of effect on detected human immunodeficiency virus and hepatitis C virus infections.
46. Nondetection of the S Antigen in Saline Antiglobulin Testing.
47. Neonatal Alloimmune Thrombocytopenia Due to Anti-HPA-2b (anti-Ko[sup a]).
48. Implementation of sexual risk behavior donor screening in Canada.
49. Monitoring syphilis serology in blood donors: Is there utility as a surrogate marker of early transfusion transmissible infection behavioral risk?
50. Navigating imperfect policies to donate plasma: Survey on plasma donation and a pilot plasma donation program among men who have sex with men in Canada.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.